Guo Zhang

Dr. Guo Zhang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2026 in Cancers
Verified
Journal Article
Open access
PDF file
THTing Huang
Ting Huang
XXXinyu Xie
Xinyu Xie
XDXinqiao Du
Xinqiao Du
XSXiuling Sun
Xiuling Sun
GZGuo Zhang
Guo Zhang
JWJianliu Wang
Jianliu Wang
Background: Uterine sarcomas are rare, heterogeneous malignancies with distinct pathological behaviors. This study aimed to identify clinicopathological characteristics, prognostic risk factors, and potential therapeutic targets to enhance clinical management. Methods: A retrospective analysis was conducted on 148 patients with uterine sarcoma treated at Peking University People’s Hospital between 1996 and 2025. Clinical outcomes, pathological subtypes, and immunohistochemical profiles were assessed. Additionally, bioinformatics analyses from RNA bulk sequencing of GEO datasets (GSE87581, GSE85383, GSE222045 and GSE64763) were performed to elucidate molecular characteristics across subtypes. Results: The most prevalent subtypes were uterine leiomyosarcoma (uLMS; 38.5%) and low-grade endometrial stromal sarcoma (LG-ESS; 29.7%). The 5-year recurrence rate was 50.5%, with frequent metastases to the pelvis and lungs. LG-ESS demonstrated the most favorable 5-year survival rate (90.3%), significantly higher than that of uLMS (61.8%) and undifferentiated uterine sarcoma (50.0%). Multivariate analysis identified histological subtype, stage, and coagulative necrosis as independent prognostic factors for overall and progression-free survival. Transcriptomic profiling revealed immunosuppression (CSF1R/CSF3R expression) in high-grade ESS, while uLMS exhibited activation of cell cycle and homologous recombination pathways. Conclusions: Histological subtype, stage, and coagulative necrosis were critical prognostic factors in uterine sarcoma. The findings suggest that vigilant pulmonary surveillance and further investigation into tailored therapeutic strategies may be warranted-including endocrine therapy for hormone-receptor-positive tumors, immunotherapy for high-grade ESS, and PARP inhibitors for uLMS. However, these hypotheses require thorough preclinical and clinical validation. Additionally, caution should be exercised to avoid overtreatment of chemotherapy in early-stage uLMS.

1 December 2025 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
YDYangyang Dong
Yangyang Dong
HLHe Li
He Li
YDYibo Dai
Yibo Dai
LLLiwei Li
Liwei Li
GZGuo Zhang
Guo Zhang
JWJianliu Wang
Jianliu Wang
Background: Laparoscopy for early/low-risk endometrial cancer (EC) is safe, but evidence for high-risk cases is insufficient. This study aimed to compare perioperative safety and survival outcomes between high-risk EC patients receiving laparoscopic surgery and laparotomy. Methods: A total of 267 high-risk EC patients (stage IA, grade 3; stage IA, type II tumors; stage IB-III, regardless of histologic grade) undergone surgery in Peking University People’s Hospital from 2006 to 2016 were retrospectively enrolled in the study. To evaluate the safety of laparoscopic surgery, the incidence of perioperative complications and long-term oncological outcomes were compared between patients receiving laparoscopic surgery or laparotomy. Survival analysis was performed using the Kaplan-Meier method and Cox regression. Results: Laparoscopic approach was associated with shorter mean operative time (183.0±60.3 vs. 202.3±67.0 mins, P=0.02), less blood loss (210.2±255.5 vs. 484.9±328.2 mL, P<0.001) and lower transfusion rate (10.4% vs. 31.6%, P<0.001) than laparotomy. Both Kaplan-Meier method and univariate Cox regressions showed that laparoscopic surgery and laparotomy had similar 5-year disease-free (88.8% vs. 84.6%, P=0.33) and overall survival (95.6% vs. 90.2%, P=0.58). In multivariate analysis, both stage and grade were associated with oncological outcomes whereas surgical approach was not a risk factor for prognosis. Conclusions: Laparoscopic surgery is effective and safe in high-risk EC, though further validations by randomized clinical trials are needed.